Related Experiment Video
Updated: Feb 19, 2026

09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.6K
Next generation sequencing as a follow-up test in an expanded newborn screening programme.
Andraz Smon1, Barbka Repic Lampret1, Urh Groselj1
1University Medical Centre Ljubljana, University Children's Hospital, Bohoriceva 20, Ljubljana, Slovenia.
Clinical Biochemistry
|November 8, 2017
Summary
This pilot study introduced expanded newborn screening (NBS) in Slovenia using tandem mass spectrometry and next-generation sequencing (NGS). Results show NBS can effectively identify inborn errors of metabolism (IEM), paving the way for routine implementation.
Area of Science:
- Biochemistry
- Genetics
- Public Health
Background:
- Most Southeastern European countries lack expanded newborn screening (NBS) programs.
- This study is among the first expanded NBS initiatives in Southeastern Europe.
- Estimating the incidence of inborn errors of metabolism (IEM) in Slovenia is crucial.
Purpose of the Study:
- To conduct an expanded NBS pilot study in Slovenia.
- To estimate the incidence of IEM in the Slovenian population.
- To evaluate the utility of next-generation sequencing (NGS) in NBS.
Main Methods:
- A pilot study involving 10,048 newborn screening cards.
- Utilized tandem mass spectrometry followed by NGS for confirmatory analysis.
- 85 children underwent metabolic follow-up, with 80 analyzed by NGS.
Main Results:
- Confirmed one case of glutaric acidemia type 1.
- Identified a suspected very long-chain acyl-CoA dehydrogenase deficiency case with heterozygous variants.
- Detected elevated metabolites for 3-methylcrotonyl-CoA carboxylase deficiency in nine participants.
- Cumulative incidences of IEM were comparable to other European countries.
Conclusions:
- NGS is valuable for differentiating affected patients from heterozygotes and improving genetic analysis turnaround time.
- The study provides essential data for the routine implementation of expanded NBS in Slovenia.
- Expanded NBS is feasible and beneficial for early detection of IEM.
Related Concept Videos
Next-generation Sequencing
99.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.2K
Sanger Sequencing
775.4K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
775.4K
RNA-seq
12.2K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.2K

